Breakout Ventures Investor
The era of Creative Bioscience is here. Biology, chemistry and technology are converging, challenging the traditional boundaries of science and unlocking new possibilities. We invest in early-stage companies building bio-based solutions to dramatically improve human health and the sustainability of our planet. ︎ CYTOVALE
Number Of Exists:
2
Investor Type:
Micro VC
Investment Stage:
Early Stage Venture, Seed
Employee Number:
1-10
Headquarters:
San Francisco, California, United States
Founded Date:
2016-08-01
Industry:
Advanced Materials, Energy, Financial Services, Life Science, Venture Capital
Estimated Revenue:
$1M to $10M